Timeline
inobrodib
Oral p300/CBP inhibitor in development by CellCentric for relapsed/refractory multiple myeloma.
1 of 1 entries (1 events, 0 interactions)
Filters
#4 5 May
Oral p300/CBP inhibitor in development by CellCentric for relapsed/refractory multiple myeloma.
1 of 1 entries (1 events, 0 interactions)